Lineu Prestes, 748, Cidade Universitria, So Paulo 05508-000, Brazil [email protected] This article was submitted to Chemical Biology, a section of the journal Frontiers in Molecular Biosciences Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Months three to six: visible progress Most users begin noticing visible improvements between months three and six
The most common side effect involves mild injection site irritation, affecting 2.8% of women in controlled studies
In addition, the same study also showed that the treatment of erastin (an inducer of iron toxicity) decreased GPX4 and ferritin levels in human epidermal melanocytes (HEMs) while increasing TfR and Acyl-CoA synthetase long-chain family member 4 (ACSL4) expression, indicating that HEMs are sensitive to ferroptosis (97)
North America and Europe represent substantial and growing markets, often sourcing products from Asian manufacturers
Weeks 7-12 Consolidation Reduce to 23 topical uses or 2 injections per week Optional stack: PRP, red-light therapy, or NAD+ IV for synergistic repair Month 4+ Maintenance Pulse cycles (4 weeks on / 4 weeks off) or topical-only upkeep Quarterly VISIA scans, ultrasound, or tricho-scan hair counts 7